Abintus Bio Company
Abintus Bio engages in the field of in vivo immune cell reprogramming.
Technology:
CAR-T therapy, Cell-based gene therapy, Others
Industry:
Gene Therapy, Private
Headquarters:
San Diego, California, United States
Founded Date:
2020-01-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
13652623
Last Funding Date:
2022-08-15
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership